Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:56 PM
Ignite Modification Date:
2025-12-24 @ 11:56 PM
NCT ID:
NCT00659451
Eligibility Criteria:
Inclusion Criteria:
* Gender: 50% Male and 50 % female
* Age: 40-80 years
* Race: caucasian
* Well controlled type II Diabetes : fasting glicemia \< 126 mg/dl in two different determinantion or any non fasting glicemia \> 200 mg/dl; HbA1c \< 7%
* Mild to moderate hypertension (BP\>130/80mmHg; \<160/100mmHg)
* Left ventricular hypertrophy (LVMI \> 131/110 g/m2 in males/females respectively)
Exclusion Criteria:
* other anthypertensive treatment after wash out period of 2 weeks
* abnormal heart rest function (EF \< 55%).
* valvular heart disease
* congenital heart disease
* heart failure or prior myocardial infarction
* renal disease
* liver disease
* connective tissue disease
* pregnancy or lactation
* sensitivity to the study drugs
* contraindication from an approved label
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
40 Years
Maximum Age:
80 Years
Study:
NCT00659451
Study Brief:
Protocol Section:
NCT00659451